FDA Clearance Tracker · P910018-S005
LIPOSORBER LA-15 SYSTEM
Last checked: Nov 20, 2026Latest source record: Dec 6, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Dec 6, 2000
Approved
Time to decision
169 days
Received Jun 20, 2000. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P910018-S005
- Device name
- LIPOSORBER LA-15 SYSTEM
- Applicant
- Kaneka Pharma America Corp.
- Applicant location
- New York, NY
- Received
- Jun 20, 2000
- Decided
- Dec 6, 2000
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P910018
Device type
- Device type
- Lipoprotein, low density, removal (MMY)
- Device class
- Class III
- Specialty
- GI, Urology & Nephrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR 1) REPLACING THE STERILIZATION DATE WITH THE ACTUAL EXPIRATION DATE, EXPRESSED AS MONTH AND YEAR, FOR THE LIPOSORBER(R) LA-15 SYSTEM COMPONENTS: LIPOSORBER(R) LA-15 COLUMN, SULFLUX(R) FS-05 PLASMA SEPARATOR, AND THE TUBING SYTEM FOR PLASMAPHERESIS LT-MA2; 2) REPLACING THE SLIP-TYPE MALE TUBING CONNECTORS WITH LUER-LOCK TYPE CONNECTORS ON THE SEPARATOR END-CAPS OF TE SULFLUX FS-05 PLASMA SEPARATOR; 3) MAKING THE FOLLOWING CHANGES TO THE TUBING SYSTEM FOR THE PLASMAPHERESIS LT-MA2: A) PROVIDING STERILE TRANSDUCER PROTECTIVE FILTERS (FOUND SUBSTANTIALLY EQUIVALENT UNDER 510(K) K983076) IN PACKAGES OF TEN; B) REDUCING THE NUMBER OF CONNECTION TUBES FROM TEN TO EIGHT, ADDING PINCH CLIPS AND REDUCING THE SHARPNESS OF THE PLASTIC SPIKE ON EACH END OF THE CONNECTION TUBE; C) REPLACING THE STAINLESS STEEL NEEDLES, USED TO CONNECT EACH INFUSION LINE TO A BAG OR BOTTLE OF SALINE OR REGENERATION FLUID, WITH PLASTIC SPIKES; D) ADDING A LUER-LOCK "MALE" AND "FEMALE" CONNECTOR TO THE END OF THE WASTE LINES; E) INCREASING THE LENGTH OF THE TUBING SECTION BETWEEN THE BLOOD PUMP AND CHANBER LEVEL 1 FROM 80 MM TO 90 MM AND THE LENGTH OF THE TUBING SECTION BETWEEN THE WASTE DRIP CHAMBER AND A "T" DCONNECTOR ON THE WASTE LINE FROM 35 M TO 50 MM; AND F) ADDING AN INFUSION LINE.
Source documents
Other decisions for Kaneka Pharma America Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.